The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000230:Adenocarcinoma / Q000188:drug therapy / Q000276:immunology; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D008081:Liposomes / Q000494:pharmacology*; D009000:Monocytes / Q000276:immunology*; D010100:Oxygen / Q000096:biosynthesis*; D013481:Superoxides / Q000096:biosynthesis*
D008081:Liposomes; D013481:Superoxides; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C035295:6-O-stearoyl-N-acetylmuramyl-alanylisoglutamine; D010100:Oxygen